GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » AfterNext HealthTech Acquisition Corp (NYSE:AFTR) » Definitions » Cash Ratio

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Cash Ratio : 0.00 (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is AfterNext HealthTech Acquisition Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. AfterNext HealthTech Acquisition's Cash Ratio for the quarter that ended in Jun. 2023 was 0.00.

AfterNext HealthTech Acquisition has a Cash Ratio of 0.00. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for AfterNext HealthTech Acquisition's Cash Ratio or its related term are showing as below:

During the past 2 years, AfterNext HealthTech Acquisition's highest Cash Ratio was 0.61. The lowest was 0.03. And the median was 0.13.

AFTR's Cash Ratio is not ranked *
in the Diversified Financial Services industry.
Industry Median: 1.2
* Ranked among companies with meaningful Cash Ratio only.

AfterNext HealthTech Acquisition Cash Ratio Historical Data

The historical data trend for AfterNext HealthTech Acquisition's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AfterNext HealthTech Acquisition Cash Ratio Chart

AfterNext HealthTech Acquisition Annual Data
Trend Dec21 Dec22
Cash Ratio
0.15 0.06

AfterNext HealthTech Acquisition Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cash Ratio Get a 7-Day Free Trial Premium Member Only 0.25 0.07 0.06 0.03 -

Competitive Comparison of AfterNext HealthTech Acquisition's Cash Ratio

For the Shell Companies subindustry, AfterNext HealthTech Acquisition's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AfterNext HealthTech Acquisition's Cash Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, AfterNext HealthTech Acquisition's Cash Ratio distribution charts can be found below:

* The bar in red indicates where AfterNext HealthTech Acquisition's Cash Ratio falls into.



AfterNext HealthTech Acquisition Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

AfterNext HealthTech Acquisition's Cash Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash Ratio (A: Dec. 2022 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.678/11.945
=0.06

AfterNext HealthTech Acquisition's Cash Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cash Ratio (Q: Jun. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.021/11.956
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AfterNext HealthTech Acquisition  (NYSE:AFTR) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


AfterNext HealthTech Acquisition Cash Ratio Related Terms

Thank you for viewing the detailed overview of AfterNext HealthTech Acquisition's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
301 Commerce Street, Suite 3300, City Fort Worth, TX, USA, 76102
Website
AfterNext HealthTech Acquisition Corp is a blank check company.
Executives
Jon Winkelried director, 10 percent owner C/O GOLDMAN, SACHS & CO., 85 BROAD STREET, NEW YORK NY 10004
Tpg Gp A, Llc director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
R Halsey Wise director, officer: Chief Executive Officer 135 PONTE VEDRA BLVD, PONTE VEDRA BEACH FL 32082
Julie L. Gerberding director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
David Bonderman director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
James G Coulter director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Tpg Group Holdings (sbs) Advisors, Inc. director, 10 percent owner C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Jeffrey K. Rhodes director C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Christopher H. Hunter director 500 W MAIN STREET, LOUISVILLE KY 40202
Bharat Sundaram director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Martin Davidson officer: Chief Financial Officer C/O TPG PACE ENERGY HOLDINGS CORP., 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Nehal Raj director C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Anthony Jr Colaluca director, officer: President MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
William Joseph Miller director 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Agneta G. Breitenstein director C/OAFTERNEXT HEALTHTECH ACQUISITION CORP, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Headlines